Company intelligence / Profile preview

Synevo

Ownership: Private
Development stage: Commercial

Overview

Synevo is a leading European network of medical laboratories specializing in routine and advanced diagnostics, pathology, molecular diagnostics, and central lab support for clinical trials. It serves millions of patients annually across multiple countries with a broad test menu exceeding 3,000 analyses. The company is recognized for its quality standards and digital platforms supporting both healthcare providers and research sponsors.

Industry: Molecular Diagnostics

Partnerships

Pharmaceutical/biotech companiesCROsHospitalsUniversities

Beyond the preview

Go deeper on Synevo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synevo.

Explore the full profile